Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suppression of preterm labour. Current concepts

P Johnson1

  • 1St Helier Hospital, Carshalton, Surrey, England.

Drugs
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Preterm delivery complications cause over 60% of perinatal mortality. Despite available tocolytic agents, preterm births remain unchanged, highlighting the need for improved interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corpus cavernosum-like tumor of the vulva.

Acta obstetricia et gynecologica Scandinavica·1997
Same author

A mutation analysis on GYPC, the gene encoding the Gerbich blood group antigens.

Transfusion medicine (Oxford, England)·1997
Same author

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

The American journal of medicine·1997
Same author

Determination of the optical purity of ibuprofen using X-ray powder diffraction.

Journal of pharmaceutical sciences·1997
Same author

Effects of antihypertensive drugs on rat tissue antioxidant enzyme activities and lipid peroxidation levels.

Biochemical pharmacology·1997
Same author

Chorionic villus sampling and early amniocentesis for prenatal diagnosis.

Lancet (London, England)·1997
Same journal

Ecnoglutide: First Approvals.

Drugs·2026
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Perinatology
  • Pharmacology

Background:

  • Preterm delivery affects 5-9% of pregnancies, contributing significantly to perinatal mortality.
  • Current tocolytic agents, used for over 20 years, have not reduced preterm birth rates.
  • Efficacy and safety of various tocolytic agents (ethanol, beta-agonists, NSAIDs, calcium channel blockers) have been investigated.

Purpose of the Study:

  • To review the efficacy and safety of tocolytic agents in managing preterm labor.
  • To assess the impact of tocolysis on prolonging pregnancy and improving perinatal outcomes.
  • To identify challenges in interpreting clinical trial data due to diagnostic difficulties in preterm labor.

Main Methods:

  • Literature review of studies on tocolytic agents for preterm labor.

Related Experiment Videos

  • Analysis of clinical trial data regarding the effectiveness of different therapeutic agents.
  • Evaluation of the impact of delaying delivery on corticosteroid administration.
  • Main Results:

    • Tocolytic agents can delay delivery for up to 7 days, but evidence for longer prolongation is limited.
    • Delaying delivery to administer corticosteroids has demonstrated value.
    • Diagnostic challenges in preterm labor complicate the interpretation of clinical trial results.

    Conclusions:

    • Despite widespread use, tocolytic agents have not decreased preterm birth rates.
    • The primary benefit of tocolysis appears to be facilitating antenatal corticosteroid administration.
    • Further research is needed to overcome diagnostic uncertainties and improve the effectiveness of preterm birth prevention.